搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
360dx
1 天
MagIA Diagnostics Developing POC STD Tests to Prevent Mother-to-Child Transmission
The company, based outside of Grenoble in the French Alps, together with its partners has received €5 million to pursue the project.
India Today on MSN
2 天
New innovative drug provides relief from abdominal pain
Austrian researchers have developed an oxytocin drug that is stable in the gut for those who have abdominal pain. This is a ...
2 天
Doctor says 'common' symptoms are sign of low-survival cancer
Pancreatic cancer may manifest with several follow-on symptoms, including: Loss of appetite: A decreased appetite is common ...
2 天
'Common' symptoms could be early sign of cancer with very low survival rate
If you find that your skin and eyes are becoming more yellow in complexion, your urine is a darker shade of yellow or orange ...
2 天
Doctor's 'common' signs could be early red flag for low-survival cancer
Pancreatic cancer has a low survival rate, largely due to the fact that it is difficult to diagnose at an early stage ...
Medindia
2 天
Oral Oxytocin-Like Peptides: A Non-Opioid Approach to Chronic Abdominal Pain
An oral peptide therapy for chronic abdominal pain has been developed, providing a safe, non-opioid alternative for ...
Ross-shire Journal
3 天
WATCH: ‘My smear test saved my life’ says Highland woman fighting cervical cancer
An Inverness woman shares how a routine smear test saved her life, helping doctors detect cervical cancer in her brave battle ...
Northwich Guardian
3 天
Send a message of hope to help veterans find the peace they deserve
He takes strong prescription opioid medication to try to relieve the chronic pain, but this has caused him to suffer with IBS (irritable bowel syndrome), liver damage and incontinence. His insomnia ...
News Medical
4 天
New oral peptide therapy offers hope for chronic abdominal pain
A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈